ALBIREO PHARMA, INC.·4

Jan 23, 5:11 PM ET

Mattsson Jan 4

4 · ALBIREO PHARMA, INC. · Filed Jan 23, 2023

Insider Transaction Report

Form 4
Period: 2023-01-23
Mattsson Jan
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2023-01-23$43.80/sh197$8,62954,474 total
Footnotes (2)
  • [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]Represents 35,524 shares of common stock and 18,950 restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION